Market open

Axogen/$AXGN

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Axogen

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

Ticker

$AXGN
Trading on

Industry

Health Care Equipment & Supplies

Employees

427

Axogen Metrics

BasicAdvanced
$615M
Market cap
-
P/E ratio
-$0.33
EPS
1.13
Beta
-
Dividend rate
$615M
1.13
$14.86
$4.97
413K
3.745
2.134
69.865
71.732
-1.03%
-2.75%
-14.51%
3.358
6.18
6.53
-61.348
18.79%
-40.02%
12.12%
-21.40%

What the Analysts think about Axogen

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Axogen stock.

Axogen Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Axogen Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $AXGN

$

Sign up or log in to buy
Capital at risk
Market open

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Axogen stock?

Axogen (AXGN) has a market cap of $615M as of November 12, 2024.

What is the P/E ratio for Axogen stock?

The price to earnings (P/E) ratio for Axogen (AXGN) stock is 0 as of November 12, 2024.

Does Axogen stock pay dividends?

No, Axogen (AXGN) stock does not pay dividends to its shareholders as of November 12, 2024.

When is the next Axogen dividend payment date?

Axogen (AXGN) stock does not pay dividends to its shareholders.

What is the beta indicator for Axogen?

Axogen (AXGN) has a beta rating of 1.13. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.